CVS Health (CVS) Tops Q3 EPS by 20c, Lifts FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
CVS Health (CVS) PT Raised to $115 at Cantor Fitzgerald
November 3, 2021 1:33 PM EDTCantor Fitzgerald analyst Steven Halper raised the price target on CVS Health (NYSE: CVS) to $115.00 (from $95.00) while maintaining an Overweight rating following earnings.
The analyst commented, "We reiterate our Overweight rating on CVS shares and increase our 12-month price target to $115 from $95.... More
CVS Health (CVS) Announces Availability of Pfizer-BioNTech COVID-19 Vaccine to Children Aged 5-11
November 3, 2021 10:01 AM EDTCVS Health (NYSE: CVS) today announced that select CVS Pharmacy locations will be offering a two-dose primary series of the Pfizer-BioNTech COVID-19 pediatric vaccine to children ages five to 11 years of age starting on Sunday, 11/7, upon receipt and confirmation of vaccine supply. This follows authorization of the vaccine by the Centers for Disease Control and Prevention (CDC) based on guidance from the organization's Advisory Committee on Immunization Practices and Food and Drug Administration (FDA) Emergency Use Authorization. Parental or legal guardian consent is required for this age group, and children must be... More
